[
  {
    "ts": null,
    "headline": "Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now",
    "summary": "FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.",
    "url": "https://finnhub.io/api/news?id=8c1a5f5370400e94b98b48b1acbf3ae9eed175199d70cccb30409bd892a96733",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761328140,
      "headline": "Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now",
      "id": 137218217,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.",
      "url": "https://finnhub.io/api/news?id=8c1a5f5370400e94b98b48b1acbf3ae9eed175199d70cccb30409bd892a96733"
    }
  },
  {
    "ts": null,
    "headline": "West to Participate in Upcoming Investor Conferences",
    "summary": "West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences:",
    "url": "https://finnhub.io/api/news?id=65adde6be0ee3811160b757ee41451d20654cf35d850fbf12557621212f7e2ea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761300000,
      "headline": "West to Participate in Upcoming Investor Conferences",
      "id": 137218218,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences:",
      "url": "https://finnhub.io/api/news?id=65adde6be0ee3811160b757ee41451d20654cf35d850fbf12557621212f7e2ea"
    }
  },
  {
    "ts": null,
    "headline": "WST Q3 Deep Dive: GLP-1 Demand, Annex 1 Upgrades, and Margin Expansion Shape Outlook",
    "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.7% year on year to $804.6 million. The company’s full-year revenue guidance of $3.07 billion at the midpoint came in 0.5% above analysts’ estimates. Its non-GAAP profit of $1.96 per share was 16.3% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=daf3092a632890ab05b009bce66e084c32b7274ff34b34916cd1ce14f91e0b7a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761283989,
      "headline": "WST Q3 Deep Dive: GLP-1 Demand, Annex 1 Upgrades, and Margin Expansion Shape Outlook",
      "id": 137218219,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.7% year on year to $804.6 million. The company’s full-year revenue guidance of $3.07 billion at the midpoint came in 0.5% above analysts’ estimates. Its non-GAAP profit of $1.96 per share was 16.3% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=daf3092a632890ab05b009bce66e084c32b7274ff34b34916cd1ce14f91e0b7a"
    }
  },
  {
    "ts": null,
    "headline": "West Pharmaceutical Services, Inc. 2025 Q3 - Results - Earnings Call Presentation",
    "summary": "2025-10-24. The following slide deck was published by West Pharmaceutical Services, Inc.",
    "url": "https://finnhub.io/api/news?id=a3af9f800552dfd4245ec89cd4f369ddf1bfc97a345b4d8156a3fb25a3d93e17",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761273057,
      "headline": "West Pharmaceutical Services, Inc. 2025 Q3 - Results - Earnings Call Presentation",
      "id": 137200787,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "WST",
      "source": "SeekingAlpha",
      "summary": "2025-10-24. The following slide deck was published by West Pharmaceutical Services, Inc.",
      "url": "https://finnhub.io/api/news?id=a3af9f800552dfd4245ec89cd4f369ddf1bfc97a345b4d8156a3fb25a3d93e17"
    }
  },
  {
    "ts": null,
    "headline": "Evercore ISI Group Maintains West Pharmaceutical Services (WST) Outperform Recommendation",
    "summary": "Evercore ISI Group Maintains West Pharmaceutical Services (WST) Outperform Recommendation",
    "url": "https://finnhub.io/api/news?id=9a2625b9b49691769b393a7f9f04d861564b80f59b2c399091e6fb5c9c871055",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761264328,
      "headline": "Evercore ISI Group Maintains West Pharmaceutical Services (WST) Outperform Recommendation",
      "id": 137199612,
      "image": "",
      "related": "WST",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=9a2625b9b49691769b393a7f9f04d861564b80f59b2c399091e6fb5c9c871055"
    }
  }
]